Ishita Drugs & Industries Ltd
Ishita Drugs & Industries Ltd Live Price Chart
Ishita Drugs & Industries Ltd Technicals
| 20 Day | ₹ 71.623 |
| 50 Day | ₹ 72.969 |
| 100 Day | ₹ 74.082 |
| 200 Day | ₹ 75.338 |
| 20 Day | ₹ 71.599 |
| 50 Day | ₹ 73.402 |
| 100 Day | ₹ 74.328 |
| 200 Day | ₹ 75.888 |
Ishita Drugs & Industries Ltd Performance
| Previous Close | ₹ 70.12 |
| High | ₹ 72.98 |
| Volume | 5 |
| 52W Range | ₹ 62.35 - ₹ 90.85 |
| Open | ₹ 72.98 |
| Low | ₹ 72.98 |
| Market Cap | ₹ 22 Cr |
Ishita Drugs & Industries Ltd Fundamentals
| ROCE | 10.561 |
| P/E Ratio | 22.460 |
| P/B Ratio | 1.940 |
| Industry P/E | 1.940 |
| Debt to Equity | 39.407 |
| ROE | 8.647 |
| EPS | 3.250 |
| Dividend Yield | 0.000 |
| Book Value | 37.575 |
| Face Value | 10.000 |
Ishita Drugs & Industries Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 15.3329673 | 15.4678249 | 12.2728609 | 14.1966545 | 14.2625751 |
| Total Expenses | 14.1778259 | 14.4805661 | 11.4934195 | 13.1536863 | 13.2088364 |
| Profit After Tax | 0.8680906 | 0.7485011 | 0.5773984 | 0.8049668 | 0.8296227 |
Ishita Drugs & Industries Ltd Shareholding Pattern
| Promoter Holdings | 50.037 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 46.331 % |
| Others - | 3.631 % |
About Ishita Drugs & Industries Ltd
History of Ishita Drugs & Industries Ltd
Ishita Drugs & Industries Limited was incorporated in February, 1992 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient. The company supplies its products to leading pharmaceutical companies of India. The products are also being exported to various countries across the world. The plant has been designed and constructed to meet GMP norms. The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture, the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in Gujarat, to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not achievable. The Company gradually formed a vertically integrated industry chain covering Drug Intermediates, Active Pharma Ingredients (APIs), excipients and finished dosage forms. The Group has 3 manufacturing facilities located in Gujarat, 2 for APIs and drug intermediates (at Ahmedabad and Surendranagar) and 1 for finished pharmaceutical formulations (at Mehsana). Thereafter, the Company set up a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production ...
